CN107348483A - A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical - Google Patents

A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical Download PDF

Info

Publication number
CN107348483A
CN107348483A CN201710543693.2A CN201710543693A CN107348483A CN 107348483 A CN107348483 A CN 107348483A CN 201710543693 A CN201710543693 A CN 201710543693A CN 107348483 A CN107348483 A CN 107348483A
Authority
CN
China
Prior art keywords
pregnant
women
lying
vitamin
nutritious supplementary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710543693.2A
Other languages
Chinese (zh)
Inventor
阎艺方
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201710543693.2A priority Critical patent/CN107348483A/en
Publication of CN107348483A publication Critical patent/CN107348483A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

The present invention relates to medicine and nutritional supplement arts, more particularly to a kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical.Pregnant and lying-in women's full function nutritious supplementary pharmaceutical of the present invention is by polydextrose, skimmed milk powder, whole-fat milk powder, lactalbumin, galactooligosaccharide, FOS, oligoisomaltose, lactose, yam flour, jujube powder, DHA algal oil, corn syrup solid, sodium ascorbate, casein sodium, sodium citrate, phosphatide, L ascorbic acid, bata-carotene, nicotinic acid, riboflavin, axerophtholum aceticum, D calcium pantothenates, folic acid, tocopherol, puridoxine hydrochloride, thiamine hydrochloride, cyanocobalamin, vitamine D3, taurine, newborn mineral salt, magnesium sulfate, zinc gluconate, made of sodium iron ethylene diamine tetra acetate and CPP, it is preferred that electuary and chewable tablet.Nutritional supplementation agent prescription of the present invention is reasonable, effect is comprehensive, edible safety, and through experiment, science takes nutritious supplementary pharmaceutical of the present invention and is remarkably improved pregnant and lying-in women's immunity.

Description

A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical
Technical field
The present invention relates to medicine and nutritional supplement arts, more particularly to a kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical.
Background technology
Nutritious supplementary pharmaceutical, also known as dietary supplements, refer to the amino for containing some specific nutritions element, supplementing needed by human body The nutritional agents of acid, trace element, vitamin, mineral matter etc..A kind of supplementary means of the nutritious supplementary pharmaceutical as diet, makes up Possible insufficiency of intake in mankind's normal meals, while be nutrient necessary to human body again, and finally realize regulation human normal The purpose of physiological activity.
All ages and classes, sex, the crowd of body condition are due to the difference of its physiological condition, the species sum of required nutrient Amount is often obvious different, and therefore, the nutritious supplementary pharmaceutical of special formulation composition is developed for specific crowd turns into medicine food row The widespread consensus of industry.
At present, researcher have developed some nutritional supplement products specifically for pregnant and lying-in women.For example, patent Shen A kind of maternal nutritional reinforcing please be disclosed in CN2015102135883 " a kind of maternal nutritional fortified compositions and preparation method thereof " Composition, by yeast beta-dextran, ferric pyrophosphate, tricalcium phosphate, inulin, trehalose, WPC, red date powder and soybean Separated protein powder is made.Patent application CN2015106186649 " a kind of maternal nutritional premix and includes maternal nutritional premix Food " in disclose a kind of maternal nutritional premix, including following nutrient：Vitamin A, vitamin D, vitamin E, dimension life Plain K, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, nicotinic acid etc..Patent of invention Disclosed in CN2012105859417 " be used for strengthen maternal nutritional and the preparation of brain health care of children " it is a kind of be used for maternal nutritional and The preparation of brain health care of children, it is made by marine alga DHA, taurine, soybean lecithin and lactalbumin.Patent application CN201110460853X discloses a kind of addition DHA and is adapted in " a kind of addition DHA is adapted to the red jujube thick syrup that pregnant woman wet nurse eats " The red jujube thick syrup that pregnant woman wet nurse eats, by DHA, AA, phytosterol, oligoisomaltose, phosphatide, vitamin A, vitamin B3, Vitamin C, vitamine D3, folic acid, taurine, calcium, iron, zinc etc. are made.
The present invention, by proportioning test repeatedly, further optimizes pregnant and lying-in women's nutrition benefit on the basis of the said goods The formula composition and component content proportioning of agent are filled, a kind of full function nutrition for being extremely suitable for pregnant and lying-in women and eating finally has been made Replenishers, nutritional supplementation agent prescription of the present invention rationally, effect comprehensively, edible safety, science, which is taken, to be remarkably improved pregnant and lying-in women and exempts from Epidemic disease power, auxiliary fetal brain and body development, prevention pregnant and lying-in women and fetus anaemia.
The content of the invention
The invention provides a kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical, it is characterised in that it is by following weight parts Made of raw material：
Polydextrose 12-30；Skimmed milk powder 3.9-5.4；Whole-fat milk powder 6.4-6.7；Lactalbumin 3.2-3.5；Oligomeric half Lactose 4.1-5.2；FOS 4.65-5.80；Oligoisomaltose 3.03-3.25；Lactose 7.2-7.5；Yam flour 3.6- 4.0；Jujube powder 3.0-3.2；DHA algal oil 1.65-1.72；Corn syrup solid 20-28；Sodium ascorbate 0.037-0.049；Junket Protein acid sodium 0.65-0.82；Sodium citrate 0.93-1.49；Phosphatidase 2 .52-2.70；L-AA 0.16-0.20；β-carrot Plain 0.85-1.45；Nicotinic acid 0.005-0.035；Riboflavin 0.001-0.006；Axerophtholum aceticum 0.0009-0.0042；D-VB5 Calcium 0.002-0.075；Folic acid 0.0002-0.0009；Tocopherol 0.009-0.024；Puridoxine hydrochloride 0.001-0.006；Hydrochloric acid Thiamine 0.001-0.006；Cyanocobalamin 0.000001-0.000012；Vitamine D3 0.000001-0.000013；Taurine 0.08-0.15；Newborn mineral salt 1.6-2.7；Magnesium sulfate 0.26-0.70；Zinc gluconate 0.052-0.126；Ethylenediamine tetra-acetic acid Ferrisodium 0.105-0.625；CPP 0.23-0.26.
The parts by weight of above-mentioned raw materials are preferred：
Polydextrose 20；Skimmed milk powder 4.4；Whole-fat milk powder 6.5；Lactalbumin 3.3；Galactooligosaccharide 4.5；FOS 4.95；Oligoisomaltose 3.15；Lactose 7.3；Yam flour 3.8；Jujube powder 3.2；DHA algal oil 1.69；Corn syrup solid 24； Sodium ascorbate 0.039；Casein sodium 0.72；Sodium citrate 1.21；Phosphatidase 2 .60；L-AA 0.18；Beta carotene 1.05；Nicotinic acid 0.015；Riboflavin 0.002；Axerophtholum aceticum 0.0022；D-VB5 calcium 0.015；Folic acid 0.0004；Tocopherol 0.012；Puridoxine hydrochloride 0.002；Thiamine hydrochloride 0.003；Cyanocobalamin 0.000003；Vitamine D3 0.000003；Taurine 0.12；Newborn mineral salt 1.9；Magnesium sulfate 0.46；Zinc gluconate 0.082；Sodium iron ethylene diamine tetra acetate 0.175；Casein phosphoric acid Peptide 0.24.
Further, the nutritional ingredient of following weight is contained per 100g pregnant and lying-in women's full function nutritious supplementary pharmaceuticals of the present invention：
Protein 9.5-10.2g；Fatty 5.2-5.4g；Carbohydrate 50.5-53.0g；Dietary fiber 22.5-24.0g； Sodium 108-112mg；Vitamin A 1350-1365 μ g；Vitamin D 1.8-2.0 μ g；Vitamin E 14.85-15.05mg；Dimension life Plain B1 1.65-1.72mg；Vitamin B2 1.66-1.70mg；Vitamin B6 1.66-1.70mg；Vitamin B12 4.64- 4.70μg；Vitamin C 185.0-185.6mg；Nicotinic acid 20.60-20.75mg；Folic acid 368-378 μ g；Pantothenic acid 5.45-5.55mg； Magnesium 136-141mg；Calcium 990-1020mg；Iron 18.4-18.7mg；Zinc 13.79-13.82mg；Taurine 119-123mg.
Preferably, the nutritional ingredient containing following weight in every 100g pregnant and lying-in women's full function nutritious supplementary pharmaceuticals of the present invention：
Protein 9.8g；Fatty 5.3g；Carbohydrate 52.0g；Dietary fiber 23.5g；Sodium 110mg；Vitamin A 1360μg；The μ g of vitamin D 1.9；Vitamin E 15.00mg；Vitamin B1 1.68mg；Vitamin B2 1.68mg；Vitamin B6 1.68mg；The μ g of vitamin B12 4.67；Vitamin C 185.4mg；Nicotinic acid 20.70mg；The μ g of folic acid 376；Pantothenic acid 5.49mg；Magnesium 140mg；Calcium 1000mg；Iron 18.6mg；Zinc 13.80mg；Taurine 120mg.
We have discovered that there is mutually interdependent during absorbing and acting on performance between different classes of nutrient Deposit, condition each other, synergistic relation.If carrying out the nutritional supplementation of single kind, internal nutrition on the one hand can be destroyed Environment, cause nutrient imbalance, on the other hand, its absorption also tends to unsatisfactory with action effect.Such as：
(1) according to investigations, having quite a few in the pregnant and lying-in women and children of China's hypoferric anemia is replenished the calcium caused by excess, Reason is that calcium belongs to divalent ion together with iron, and excessive calcium can hinder the absorption of iron.Therefore our formula adds while replenishing the calcium The iron of specified quantitative is added, it is offset inhibition caused by the absorption of normal ferro element of verifying of replenishing the calcium just.
(2) there is no vitamin D cooperation in calcium supplementing product, effect of supplemented calcium is poor.
(3) single benefit iron, without ascorbic participation, the assimilation effect of iron is very undesirable.
(4) DHA is used merely, cerebrum tonifying effect is very limited.Itself and lecithin, taurine are used cooperatively by we, make it The effect of brain development is promoted to be remarkably reinforced.
Further, the raw material of pregnant and lying-in women's full function nutritious supplementary pharmaceutical of the present invention, which is made, also includes following weight parts： Garlic P.E 1.05-1.20.
Preferably, the garlic P.E is made by following methods：Fresh garlic is taken to be squeezed the juice after removing the peel, gained squeezeding juice Ultrafiltration is carried out using the milipore filter that molecular weight is 500-600 that dams through centrifuged supernatant, after gained filtrate is freeze-dried i.e. Obtain garlic P.E.
It is well known that garlic P.E has the function that strengthen immunity, but the garlic extraction prepared using conventional method Thing can produce certain stimulation to pregnant and lying-in women's intestines and stomach, therefore excessive from being not added with conventional pregnant and lying-in women's nutritious supplementary pharmaceutical Garlic extract, through experiment, it has been found that it is immune that garlic juice freeze-dried powder made from adding freeze-drying is remarkably improved product enhancing The effect of power, and the adverse reaction in any stimulating gastrointestinal road will not be produced.
As a preferred embodiment, pregnant and lying-in women's full function nutritious supplementary pharmaceutical of the present invention is made up of the raw material of following weight parts 's：
Polydextrose 20；Skimmed milk powder 4.4；Whole-fat milk powder 6.5；Lactalbumin 3.3；Galactooligosaccharide 4.5；FOS 4.95；Oligoisomaltose 3.15；Lactose 7.3；Yam flour 3.8；Jujube powder 3.2；DHA algal oil 1.69；Corn syrup solid 24； Sodium ascorbate 0.039；Casein sodium 0.72；Sodium citrate 1.21；Phosphatidase 2 .60；L-AA 0.18；Beta carotene 1.05；Nicotinic acid 0.015；Riboflavin 0.002；Axerophtholum aceticum 0.0022；D-VB5 calcium 0.015；Folic acid 0.0004；Tocopherol 0.012；Puridoxine hydrochloride 0.002；Thiamine hydrochloride 0.003；Cyanocobalamin 0.000003；Vitamine D3 0.000003；Taurine 0.12；Newborn mineral salt 1.9；Magnesium sulfate 0.46；Zinc gluconate 0.082；Sodium iron ethylene diamine tetra acetate 0.175；Casein phosphoric acid Peptide 0.24；Garlic P.E 1.15.
Further, pregnant and lying-in women's full function nutritious supplementary pharmaceutical is prepared into electuary or chewable tablets by this area routine The method of agent, pregnant and lying-in women's full function nutritious supplementary pharmaceutical electuary or chewable tablet of the present invention is made.
A kind of moreover, it relates to pregnant and lying-in women's full function nutritious supplementary pharmaceutical answering in pregnant and lying-in women's food is prepared With.
A kind of moreover, it relates to pregnant and lying-in women's full function nutritious supplementary pharmaceutical answering in health care for pregnant and puerperal women product are prepared With.
To sum up, pregnant and lying-in women's full function nutritious supplementary pharmaceutical of the present invention has following features：
(1) nutritional ingredient most easily lacked comprising pregnant and lying-in women and wet nurse：Calcium, magnesium, zinc, vitamin E, vitamin B1, dimension life Plain B2, vitamin B6, nicotinic acid, pantothenic acid, vitamin C etc.；
(2) nutritional ingredient additionally supplemented especially is needed comprising pregnant and lying-in women and wet nurse：It is crystal diabetin, lactalbumin, full-cream Milk powder, skimmed milk powder, oligoisomaltose, polydextrose, galactooligosaccharide, jujube powder, phosphatide, yam flour, beta carotene, Taurine, CPP etc.；
(3) DHA, phosphatide, taurine are used in combination according to a certain ratio, hence it is evident that improve the effect for promoting fetal brain development Fruit, the brain development of people completes more than 30% in foetal period, therefore foetal period cerebrum tonifying is just particularly important；
(4) vitamin B is the indispensable micronutrient of body metabolism, but its ratio was not at that time, and absorptivity is very poor, this B1, B2, B6 use special ratios in invention formula, improve assimilation effect；
(5) pregnant woman anemia is prevented, the incidence of anaemia is very high in China pregnant and lying-in women, and anaemia is strong to pregnant and lying-in women itself Health, serious harm can all be produced to development of fetus, in order to effectively prevent pregnant woman anemia, we used in formula three groups it is pre- The prescription of anti-anaemia：1. iron+VC prevents hypoferric anemia；2. folic acid+B12 prevents megaloblastic anemia；3. jujube+Chinese yam carries Take thing, rich in nutrition；
(6) barrier action of placenta is strengthened, placenta is the nutrition storehouse of fetus, excretion channel, and bacterial virus is completely cut off Barrier, healthy placenta is most important to fetal well-being, when placenta is infected by virulence factor, will lose barrier action, Foetus health is injured, in order to improve pregnant and lying-in women's immunity, strengthens the barrier action of placenta, we are especially added with formula The composition of the strengthen immunities such as VE, folic acid, beta carotene, garlic P.E；
(7) vitamin C can not only be by ferric iron back into ferrous iron, and can be chelated with iron and to form soluble small molecule network Compound, be advantageous to iron absorption, iron is applied in combination with vitamin C according to specific proportioning in inventive formulation, improves iron absorptivity 3-6 times；
(8) pregnant and lying-in women's full function nutritious supplementary pharmaceutical effect general equilibrium of the present invention, includes the following effects factor：
1. the basic factor (milk powder, lactalbumin combination), establishes essential amino acid basis；
2. the cerebrum tonifying factor (DHA, phosphatide, taurine combination), preferentially ensures fetal brain development；
3. metabolic factor (4 big B family vitamin), ensureing pregnant and lying-in women's metabolic demand, promote embryo growth and development；
4. growth factor (calcium, iron, zinc), bioavilability is improved, meets embryo growth and development demand；
5. the prebiotic factor (galactooligosaccharide, FOS, polydextrose), promote proliferation of probiotics；
6. immune factor (VA, VC, calcium, iron, beta carotene, garlic P.E), improve immunity；
7. developing the factor (VA, beta carotene, DHA), the demand of fetus visual acuity is ensured.
Full function nutritional supplementation agent prescription of the present invention is reasonable, effect is comprehensive, edible safety, and through experiment, science takes this Invention pregnant and lying-in women's full function nutritious supplementary pharmaceutical can promote pregnant and lying-in women to take in, and nutrition is balanced, significantly improves pregnant and lying-in women's immunity, promotees Enter fetal brain and body development, prevention pregnant woman anemia and pregnancy syndrome.
Embodiment
Illustrate embodiments of the present invention below by way of specific instantiation, those skilled in the art can be by this specification Disclosed content understands other advantages and effect of the present invention easily.The present invention can also pass through specific realities different in addition The mode of applying is embodied or practiced, the various details in this specification can also be based on different viewpoints with application, without departing from Various modifications or alterations are carried out under the spirit of the present invention.
Before the specific embodiment of the invention is further described, it should be appreciated that protection scope of the present invention is not limited to down State specific specific embodiment；It is also understood that the term used in the embodiment of the present invention is specific specific in order to describe Embodiment, the protection domain being not intended to be limiting of the invention.
When embodiment provides number range, it should be appreciated that except non-invention is otherwise noted, two ends of each number range Any one numerical value can be selected between point and two end points.Unless otherwise defined, in the present invention all technologies for using and Scientific terminology is identical with the meaning that those skilled in the art of the present technique are generally understood that.Except used in embodiment specific method, equipment, Outside material, according to grasp of the those skilled in the art to prior art and the record of the present invention, it can also use and this Any method, equipment and the material of the similar or equivalent prior art of method, equipment described in inventive embodiments, material come real The existing present invention.
Embodiment 1
A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical, it is made of the raw material of following weight parts：
Polydextrose 20；Skimmed milk powder 4.4；Whole-fat milk powder 6.5；Lactalbumin 3.3；Galactooligosaccharide 4.5；FOS 4.95；Oligoisomaltose 3.15；Lactose 7.3；Yam flour 3.8；Jujube powder 3.2；DHA algal oil 1.69；Corn syrup solid 24； Sodium ascorbate 0.039；Casein sodium 0.72；Sodium citrate 1.21；Phosphatidase 2 .60；L-AA 0.18；Beta carotene 1.05；Nicotinic acid 0.015；Riboflavin 0.002；Axerophtholum aceticum 0.0022；D-VB5 calcium 0.015；Folic acid 0.0004；Tocopherol 0.012；Puridoxine hydrochloride 0.002；Thiamine hydrochloride 0.003；Cyanocobalamin 0.000003；Vitamine D3 0.000003；Taurine 0.12；Newborn mineral salt 1.9；Magnesium sulfate 0.46；Zinc gluconate 0.082；Sodium iron ethylene diamine tetra acetate 0.175；Casein phosphoric acid Peptide 0.24.
Embodiment 2
A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical, it is made of the raw material of following weight parts：
Polydextrose 20；Skimmed milk powder 4.4；Whole-fat milk powder 6.5；Lactalbumin 3.3；Galactooligosaccharide 4.5；FOS 4.95；Oligoisomaltose 3.15；Lactose 7.3；Yam flour 3.8；Jujube powder 3.2；DHA algal oil 1.69；Corn syrup solid 24； Sodium ascorbate 0.039；Casein sodium 0.72；Sodium citrate 1.21；Phosphatidase 2 .60；L-AA 0.18；Beta carotene 1.05；Nicotinic acid 0.015；Riboflavin 0.002；Axerophtholum aceticum 0.0022；D-VB5 calcium 0.015；Folic acid 0.0004；Tocopherol 0.012；Puridoxine hydrochloride 0.002；Thiamine hydrochloride 0.003；Cyanocobalamin 0.000003；Vitamine D3 0.000003；Taurine 0.12；Newborn mineral salt 1.9；Magnesium sulfate 0.46；Zinc gluconate 0.082；Sodium iron ethylene diamine tetra acetate 0.175；Casein phosphoric acid Peptide 0.24；Garlic P.E 1.15.
Pharmacodynamic experiment (one)
1. experiment purpose
Observe influence of the pregnant and lying-in women's full function nutritious supplementary pharmaceutical of the present invention to mouse immunity.
2. experiment material
2.1 given the test agent
Embodiment 1-2 pregnant and lying-in women's full function nutritious supplementary pharmaceutical.
Compound method：It is configured to suspension of the concentration as 100.0mg/ml respectively using water.
2.2 experimental animal
BALB/c mouse, 18-22g, female.
3. experiment packet and given the test agent give the time
Test and set four groups, respectively 1 group of embodiment, 2 groups of embodiment, commercial samples group and blank control group altogether, every group 10 mouse.
It is 45 days that each group sample, which gives the time,.
4. experimental method
4.1 principle
Mother cell breeder reaction occurs after T lymphocyte receptors ConA is stimulated, the line in living cells particularly proliferative cell MTh (a kind of flaxen azoles nitrogen salt) can be decomposed into blue purple crystal by plastochondria hydrolase, and its OD value can reflect cell Proliferative conditions.
4.2 instruments and material
RPMI1640 cell culture fluids, calf serum, 2 mercapto ethanol, penicillin, streptomysin, concanavalin A (ConA), Hydrochloric acid, isopropanol, MTT, Hank, s liquid, PBS (PH7.2-7.4)；
Gauze or 200 eye mesh screens, 24 well culture plates, 96 well culture plates (flat), operating theater instruments, CO2gas incubator, ELIASA, 721 spectrophotometers, superclean bench, autoclave, sterile filters.
4.3 experimental procedure
4.3.1 preparation of reagents
Complete culture solution：RPMI1640 cell culture fluid filtration sterilizations, with 10% calf serum of preceding addition, 1% glutamy Amine (200mmol/L), penicillin (100U/ml), streptomysin (100 μ g/L) and 5 × 10-5Mol/L 2 mercapto ethanol, use are sterile 1mol/L HCl or 1mol/L NaOH regulation PH to 7.0-7.2, that is, obtain complete culture solution.
ConA liquid：100 μ g/ml solution, filtration sterilization, in (- 20 DEG C) preservations of low temperature refrigerator are configured to distilled water.
Sterile Hank ' s liquid：With preceding with 3.5% sterile NaHCO3Adjust PH to 7.2-7.4.
MTT liquid：5mg MTT are dissolved in 1ml PH7.2 PBS, it is now with the current.
Acid isopropyl alcoholic solution：4ml 1mol/L HCl, prepared before use are added in 96ml isopropanols.
4.3.2 prepared by splenocyte suspension
It is sterile to take spleen, it is placed in and fills appropriate sterile Hank, in s liquid plates, gently ground spleen with tweezers, is made single thin Born of the same parents' suspension.Spleen is ground through 200 mesh sieve net filtrations, or with 4 layers of gauze, is washed 2 times with Hank ' s liquid, centrifuges 10min every time (1000r/min).Then cell is suspended in 1ml complete culture solution, (should be with platform phenol orchid dyeing counting viable count More than 95%) it is 3 × 10, to adjust cell concentration6Individual/ml.
4.3.3 lymphproliferation response
Holes will be divided to add in 24 well culture plates per a splenocyte suspension, per hole 1ml, wherein a hole adds 75 μ lConA liquid (equivalent to 7.5 μ g/ml), another hole are placed in 5%CO as control2, 72h is cultivated in 37 DEG C of incubators.Culture terminates preceding 4h, often Hole gently sucks supernatant 0.7ml, adds 0.7ml and is free of the RPMI1640 nutrient solutions of calf serum, while adds MTT (5mg/ Ml) 50 μ l/ holes, continue to cultivate 4h.After culture terminates, 1ml acid isopropyl alcohol is added per hole, piping and druming mixes, and makes purple crystal complete Fully dissolved.Then it is dispensed into 96 well culture plates, 3 parallel holes are made in each hole, and optical density is determined with 570nm wavelength with ELIASA Value.Also lysate can be directly moved into 2ml cuvettes, OD values is determined in wavelength 570nm on 721 spectrophotometers.
4.3.4 result judgement
The propagation energy of lymphocyte is represented with adding the OD value of ConA fluid apertures to subtract to be not added with the OD value of ConA fluid apertures Power, the optical density difference of test sample group are significantly higher than the optical density difference of control group, can determine that this experimental result positive.
5. experimental result
Living animal observation index
General clinical observation：Including but not limited to death condition, the state of mind, behavioral activity, morbidity, breathing, secretion, Excrement and diet and drinking-water situation etc..
Detailed clinical is observed：The including but not limited to state of mind, behavioral activity, skin, hair, eyes, ear, nose, abdomen Portion, external genital organs, anus, four limbs, foot and breathing.
Body weight：All animals after the receipt, before packet and dying preceding measure body weight.
Each experimental group optical density difference (with plus the OD value of ConA fluid apertures subtract and be not added with the OD value of ConA fluid apertures, Take the difference average value of 10 mouse of each group) it is as shown in table 1 below：
Each experimental group optical density difference of table 1
Packet n Optical density difference
Blank control group 10 0.165±0.046
Commercial samples group 10 0.444±0.151*
1 group of embodiment 10 0.793±0.123**
2 groups of embodiment 10 1.045±0.228**
Note：Compared with blank control group：*P≤0.01；**P≤0.001.
From table 1 it follows that compared with blank control group, remaining each group optical density difference substantially increases, and prompts each group The lymphopoiesis ability of mouse has strengthened.Comparatively, pregnant and lying-in women's full function nutritious supplementary pharmaceutical of the present invention (is implemented Example 1 and commercially available nutritional supplement product 2) will be substantially better than to the improvement of mouse lymphocyte multiplication capacity.It is especially needed , it is noted that embodiment 2 contains garlic P.E in being formulated, it improves immunity effect and protruded the most, adds so as to confirm It is of great advantage to enter improvement of the garlic juice freeze-dried powder to pregnant and lying-in women's immunity, while turn avoid traditional garlic extract to intestines and stomach Strong impulse acts on.
Pharmacodynamic experiment (two)
1. experiment purpose
Observe influence of the pregnant and lying-in women's full function nutritious supplementary pharmaceutical of the present invention to learning and memory in rats acquired disturbance.
2. experiment material
2.1 given the test agent
Embodiment 1-2 pregnant and lying-in women's full function nutritious supplementary pharmaceutical.
Compound method：It is configured to suspension of the concentration as 100.0mg/ml respectively using water.
2.2 experimental animal
SD rats, 5 week old, 120-140g, male and female half and half.
Experimental rat rearing conditions：22-27 DEG C of temperature, relative humidity 40-70%, freely intakes, feed, during daily illumination Between be 8h, carry out adaptability raise one week.
3. experiment packet and given the test agent give the time
Test and set four groups, respectively 1 group of embodiment, 2 groups of embodiment, commercial samples group and blank control group altogether, every group 10 rats.
It is 45 days that each group sample, which gives the time,.
4. experimental method
4.1 modeling method
Experimental rat is allowed to drink 0.5g/L lead acetate water solution modeling daily, after continuing two weeks, high lead rat model is made Mould success.
4.2 experimental method
With influence of the Shuttle box test given the test agent to resulted from chemical medicine learning and memory in rats Disorder Model.
5. experimental result
Living animal observation index
General clinical observation：Including but not limited to death condition, the state of mind, behavioral activity, morbidity, breathing, secretion, Excrement and diet and drinking-water situation etc..
Detailed clinical is observed：The including but not limited to state of mind, behavioral activity, skin, hair, eyes, ear, nose, abdomen Portion, external genital organs, anus, four limbs, foot and breathing.
Body weight：All animals after the receipt, before packet and dying preceding measure body weight.
Each experimental group rat active avoidance number and active avoidance time (taking 10 rat average values of each group) are such as table 2 below institute Show：
Each experimental group rat active avoidance number of table 2 and active avoidance time
Packet n Active avoidance number The active avoidance time (S)
Blank control group 10 8.6±3.7 133.5±51.0
Commercial samples group 10 9.4±5.3 136.4±70.6
1 group of embodiment 10 17.1±5.8* 65.9±20.4*
2 groups of embodiment 10 17.6±4.2* 63.5±22.8*
Note：Compared with blank control group：*P≤0.05.
From Table 2, it can be seen that compared with blank control group, the commercially available nutritional supplement product group rat active avoidance time With the basic indifference of active avoidance number, pregnant and lying-in women's full function nutritious supplementary pharmaceutical (Examples 1 and 2) group rat of the present invention is actively Avoid number increase, the active avoidance time is reduced, and is shown that nutritious supplementary pharmaceutical of the present invention has and is promoted brain development, improves memory Effect.
The preferred embodiments of the disclosure and embodiment are explained in detail above, but the present invention is not limited to The above-described embodiment and examples, in those skilled in the art's possessed knowledge, the present invention can also not departed from Various changes can be made on the premise of design.

Claims (10)

1. a kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical, it is characterised in that it is made of the raw material of following weight parts：It is poly- Glucose 12-30；Skimmed milk powder 3.9-5.4；Whole-fat milk powder 6.4-6.7；Lactalbumin 3.2-3.5；Galactooligosaccharide 4.1- 5.2；FOS 4.65-5.80；Oligoisomaltose 3.03-3.25；Lactose 7.2-7.5；Yam flour 3.6-4.0；Jujube powder 3.0-3.2；DHA algal oil 1.65-1.72；Corn syrup solid 20-28；Sodium ascorbate 0.037-0.049；Casein sodium 0.65-0.82；Sodium citrate 0.93-1.49；Phosphatidase 2 .52-2.70；L-AA 0.16-0.20；Beta carotene 0.85- 1.45；Nicotinic acid 0.005-0.035；Riboflavin 0.001-0.006；Axerophtholum aceticum 0.0009-0.0042；D-VB5 calcium 0.002-0.075；Folic acid 0.0002-0.0009；Tocopherol 0.009-0.024；Puridoxine hydrochloride 0.001-0.006；Hydrochloric acid sulphur Amine element 0.001-0.006；Cyanocobalamin 0.000001-0.000012；Vitamine D3 0.000001-0.000013；Taurine 0.08-0.15；Newborn mineral salt 1.6-2.7；Magnesium sulfate 0.26-0.70；Zinc gluconate 0.052-0.126；Ethylenediamine tetra-acetic acid Ferrisodium 0.105-0.625；CPP 0.23-0.26.
2. pregnant and lying-in women's full function nutritious supplementary pharmaceutical as claimed in claim 1, wherein the parts by weight of each raw material are：Polydextrose 20；Skimmed milk powder 4.4；Whole-fat milk powder 6.5；Lactalbumin 3.3；Galactooligosaccharide 4.5；FOS 4.95；Oligomeric different malt Sugar 3.15；Lactose 7.3；Yam flour 3.8；Jujube powder 3.2；DHA algal oil 1.69；Corn syrup solid 24；Sodium ascorbate 0.039；Casein sodium 0.72；Sodium citrate 1.21；Phosphatidase 2 .60；L-AA 0.18；Beta carotene 1.05；Nicotinic acid 0.015；Riboflavin 0.002；Axerophtholum aceticum 0.0022；D-VB5 calcium 0.015；Folic acid 0.0004；Tocopherol 0.012；Salt Sour pyridoxol 0.002；Thiamine hydrochloride 0.003；Cyanocobalamin 0.000003；Vitamine D3 0.000003；Taurine 0.12；Breast Mineral salt 1.9；Magnesium sulfate 0.46；Zinc gluconate 0.082；Sodium iron ethylene diamine tetra acetate 0.175；CPP 0.24.
3. pregnant and lying-in women's full function nutritious supplementary pharmaceutical as claimed in claim 1, it is characterised in that nutritional supplementation described in per 100g Nutritional ingredient containing following weight in agent：
Protein 9.5-10.2g；Fatty 5.2-5.4g；Carbohydrate 50.5-53.0g；Dietary fiber 22.5-24.0g； Sodium 108-112mg；Vitamin A 1350-1365 μ g；Vitamin D 1.8-2.0 μ g；Vitamin E 14.85-15.05mg；Dimension life Plain B1 1.65-1.72mg；Vitamin B2 1.66-1.70mg；Vitamin B6 1.66-1.70mg；Vitamin B12 4.64- 4.70μg；Vitamin C 185.0-185.6mg；Nicotinic acid 20.60-20.75mg；Folic acid 368-378 μ g；Pantothenic acid 5.45- 5.55mg；Magnesium 136-141mg；Calcium 990-1020mg；Iron 18.4-18.7mg；Zinc 13.79-13.82mg；Taurine 119- 123mg。
4. pregnant and lying-in women's full function nutritious supplementary pharmaceutical as claimed in claim 3, under often containing in nutritious supplementary pharmaceutical described in 100g State the nutritional ingredient of weight：
Protein 9.8g；Fatty 5.3g；Carbohydrate 52.0g；Dietary fiber 23.5g；Sodium 110mg；Vitamin A 1360μg；The μ g of vitamin D 1.9；Vitamin E 15.00mg；Vitamin B1 1.68mg；Vitamin B2 1.68mg；Vitamin B6 1.68mg；The μ g of vitamin B12 4.67；Vitamin C 185.4mg；Nicotinic acid 20.70mg；The μ g of folic acid 376；Pantothenic acid 5.49mg； Magnesium 140mg；Calcium 1000mg；Iron 18.6mg；Zinc 13.80mg；Taurine 120mg.
5. pregnant and lying-in women's full function nutritious supplementary pharmaceutical as claimed in claim 1, pregnant and lying-in women's full function nutrition is made and mends Filling the raw material of agent also includes following weight parts：Garlic P.E 1.05-1.20.
6. pregnant and lying-in women's full function nutritious supplementary pharmaceutical as claimed in claim 5, the garlic P.E pass through following method systems ：Fresh garlic is taken to be squeezed the juice after removing the peel, gained squeezeding juice utilizes the ultrafiltration that molecular weight is 500-600 of damming through centrifuged supernatant Film carries out ultrafiltration, and garlic P.E is obtained after gained filtrate is freeze-dried.
7. pregnant and lying-in women's full function nutritious supplementary pharmaceutical as claimed in claim 6, wherein the parts by weight of each raw material are：Polydextrose 20；Skimmed milk powder 4.4；Whole-fat milk powder 6.5；Lactalbumin 3.3；Galactooligosaccharide 4.5；FOS 4.95；Oligomeric different malt Sugar 3.15；Lactose 7.3；Yam flour 3.8；Jujube powder 3.2；DHA algal oil 1.69；Corn syrup solid 24；Sodium ascorbate 0.039；Casein sodium 0.72；Sodium citrate 1.21；Phosphatidase 2 .60；L-AA 0.18；Beta carotene 1.05；Nicotinic acid 0.015；Riboflavin 0.002；Axerophtholum aceticum 0.0022；D-VB5 calcium 0.015；Folic acid 0.0004；Tocopherol 0.012；Salt Sour pyridoxol 0.002；Thiamine hydrochloride 0.003；Cyanocobalamin 0.000003；Vitamine D3 0.000003；Taurine 0.12；Breast Mineral salt 1.9；Magnesium sulfate 0.46；Zinc gluconate 0.082；Sodium iron ethylene diamine tetra acetate 0.175；CPP 0.24； Garlic P.E 1.15.
8. pregnant and lying-in women's full function nutritious supplementary pharmaceutical as described in claim any one of 1-7, it is characterised in that the pregnant and lying-in women It is complete that this pregnant and lying-in women is further made by the conventional method for preparing electuary or chewable tablet in this area in full function nutritious supplementary pharmaceutical Functional form nutritious supplementary pharmaceutical electuary or chewable tablet.
9. the answering in pregnant and lying-in women's food is prepared of pregnant and lying-in women's full function nutritious supplementary pharmaceutical as described in claim any one of 1-7 With.
10. pregnant and lying-in women's full function nutritious supplementary pharmaceutical as described in claim any one of 1-7 is in health care for pregnant and puerperal women product are prepared Application.
CN201710543693.2A 2017-07-05 2017-07-05 A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical Pending CN107348483A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710543693.2A CN107348483A (en) 2017-07-05 2017-07-05 A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710543693.2A CN107348483A (en) 2017-07-05 2017-07-05 A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical

Publications (1)

Publication Number Publication Date
CN107348483A true CN107348483A (en) 2017-11-17

Family

ID=60291749

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710543693.2A Pending CN107348483A (en) 2017-07-05 2017-07-05 A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical

Country Status (1)

Country Link
CN (1) CN107348483A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109691606A (en) * 2017-11-24 2019-04-30 上海冬泽特医食品有限公司 A kind of beverage taken when the production for puerpera
CN110558551A (en) * 2019-09-29 2019-12-13 亨美久健康科技(广东)有限公司 full-nutrition breakfast for first stage of pregnant women and preparation method thereof
CN110574914A (en) * 2018-06-07 2019-12-17 安阳市蕴可欣健康管理有限公司 Enteral nutrition supplement suitable for Asian pregnant women
CN110720632A (en) * 2019-12-03 2020-01-24 吉林省红五味生物技术有限公司 Nutrient composition for late pregnancy and preparation method and application thereof
CN110771869A (en) * 2019-09-29 2020-02-11 亨美久健康科技(广东)有限公司 Third-stage full-nutrition breakfast for pregnant women and preparation method thereof
CN110771870A (en) * 2019-09-29 2020-02-11 亨美久健康科技(广东)有限公司 Second-stage full-nutrition breakfast for pregnant women and preparation method thereof
CN111248289A (en) * 2018-11-30 2020-06-09 内蒙古伊利实业集团股份有限公司 Composition, preparation method and application thereof
CN111602719A (en) * 2020-05-11 2020-09-01 呼伦贝尔双娃乳业有限公司 Organic formula milk powder for pregnant and lying-in women
CN117122054A (en) * 2023-09-05 2023-11-28 广西金品燕庄食品有限责任公司 Instant bird's nest product formula suitable for pregnant women

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1463745A (en) * 2002-06-14 2003-12-31 丁强 Replenisher containing complete nutrescin
CN101530195A (en) * 2008-01-28 2009-09-16 中国食品发酵工业研究院 Food formula of special diet containing oligopeptides for maternity patient
CN102511859A (en) * 2011-12-29 2012-06-27 山西汉波食品股份有限公司 Jujube high-consistency stock with docose hexaenoie acid (DHA) being suitable for pregnant women and breast-feeding women to eat
CN104920618A (en) * 2015-07-02 2015-09-23 海普诺凯营养品有限公司 Formula goat milk powder for pregnant and lying-in woman
CN106563110A (en) * 2016-11-10 2017-04-19 傅天锡 Medicine for treating postherpetic neuralgia and preparation method of medicine
CN106561840A (en) * 2016-11-16 2017-04-19 王程 Formula milk powder for relieving maternal depression and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1463745A (en) * 2002-06-14 2003-12-31 丁强 Replenisher containing complete nutrescin
CN101530195A (en) * 2008-01-28 2009-09-16 中国食品发酵工业研究院 Food formula of special diet containing oligopeptides for maternity patient
CN102511859A (en) * 2011-12-29 2012-06-27 山西汉波食品股份有限公司 Jujube high-consistency stock with docose hexaenoie acid (DHA) being suitable for pregnant women and breast-feeding women to eat
CN104920618A (en) * 2015-07-02 2015-09-23 海普诺凯营养品有限公司 Formula goat milk powder for pregnant and lying-in woman
CN106563110A (en) * 2016-11-10 2017-04-19 傅天锡 Medicine for treating postherpetic neuralgia and preparation method of medicine
CN106561840A (en) * 2016-11-16 2017-04-19 王程 Formula milk powder for relieving maternal depression and preparation method thereof

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109691606A (en) * 2017-11-24 2019-04-30 上海冬泽特医食品有限公司 A kind of beverage taken when the production for puerpera
CN110574914A (en) * 2018-06-07 2019-12-17 安阳市蕴可欣健康管理有限公司 Enteral nutrition supplement suitable for Asian pregnant women
CN111248289A (en) * 2018-11-30 2020-06-09 内蒙古伊利实业集团股份有限公司 Composition, preparation method and application thereof
CN111248289B (en) * 2018-11-30 2023-04-07 内蒙古伊利实业集团股份有限公司 Composition, preparation method and application thereof
CN110558551A (en) * 2019-09-29 2019-12-13 亨美久健康科技(广东)有限公司 full-nutrition breakfast for first stage of pregnant women and preparation method thereof
CN110771869A (en) * 2019-09-29 2020-02-11 亨美久健康科技(广东)有限公司 Third-stage full-nutrition breakfast for pregnant women and preparation method thereof
CN110771870A (en) * 2019-09-29 2020-02-11 亨美久健康科技(广东)有限公司 Second-stage full-nutrition breakfast for pregnant women and preparation method thereof
CN110720632A (en) * 2019-12-03 2020-01-24 吉林省红五味生物技术有限公司 Nutrient composition for late pregnancy and preparation method and application thereof
CN111602719A (en) * 2020-05-11 2020-09-01 呼伦贝尔双娃乳业有限公司 Organic formula milk powder for pregnant and lying-in women
CN117122054A (en) * 2023-09-05 2023-11-28 广西金品燕庄食品有限责任公司 Instant bird's nest product formula suitable for pregnant women

Similar Documents

Publication Publication Date Title
CN107348483A (en) A kind of pregnant and lying-in women's full function nutritious supplementary pharmaceutical
CN107440091A (en) A kind of children's full function nutritious supplementary pharmaceutical
Prentice et al. Dietary supplementation of Gambian nursing mothers and lactational performance
CN102985105B (en) Comprise the nutrient formulation of symphysis unit
CN105077270A (en) Nutrient supplemented composite powder as well as preparation method and use thereof
CN109198028A (en) A kind of compound protein powder nutritional food formula containing lactoferrin
CN107951025A (en) A kind of Chinese medicine health-care composition for health of losing weight
CN107691838A (en) Pet sterilization sustained release cream and preparation method thereof
CN106820151A (en) A kind of bivalve compound health composition, preparation method and application
CN105942510A (en) Medical energy nutrition component applied to pregnant and lying-in women and preparation method thereof
RU2309751C1 (en) Method for treating the disorders of mineral metabolism at arthritis, or osteochondrosis, or rickets, or arthrosis, or osteoporosis
Neumann et al. Contribution of animal source foods in improving diet quality for children in the developing world
RU2521369C1 (en) Agent or stimulation of metabolic processes, prevention and treatment of gastrointestinal diseases in calves in early postnatal period
JPH1056978A (en) Egg reinforced with vitamins and food for preventing and treating osteoporosis
US6475547B1 (en) Immunoglobulin-rich milk, production and use thereof
CN101317605B (en) Novel formulating method for functional milk powder
CN107136490A (en) A kind of peptide Chinese caterpillar fungus health product
CN113678897A (en) Formula milk powder for promoting nutrient absorption of pregnant and lying-in women and preparation method thereof
RU2675530C1 (en) Method of prevention of antenatal hypotrophy of saiga young
CN106036387A (en) Super chenopodium quinoa willd nutritional packet for promoting growth of children
CN108935701A (en) A kind of preparation method and application improving the goat milk powder of immunity, goat milk powder
CN113796467A (en) Adult dog nutrition paste and preparation method and application thereof
CN105248944A (en) Production method of potassium-rich and carotene-rich eggs
CN109287747A (en) A kind of preparation method of colostrum element
Velikanov et al. Economic efficiency of Sinoestrol-2% used for down-calving cows to stimulate non-specific resistance in newborn calves

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20171117

RJ01 Rejection of invention patent application after publication